-
Dr. P. Garrido Lopez Interprets Latest Data from CHRYSALIS
On the first day of the 2023 European Lung Cancer Congress (ELCC), during the oral presentation session, Dr. P. Garrido Lopez from Ramón y Cajal University Hospital in Madrid, Spain, presented the long-term efficacy, safety, and predictive factors of amivantamab in the treatment of platinum-treated EGFR exon 20 insertion (EGFR ex20ins) mutant advanced non-small cell…
-
ESMO Expert Commentary | Dr. Yao Zhu: Success or Failure Does Not Define a Hero, Numerous Prostate Cancer Studies Aid in Optimizing Patient Survival
Editor’s Note: Prostate cancer is the leading male urological tumor in China and has become one of the fastest-growing male malignancies in the past decade. The recent ESMO conference unveiled…
-
ESMO China Voice | Professor Bin Shao : Comprehensive Genomic Analysis of Advanced HR+/HER2- Breast Cancer Patients Using Liquid Biopsy
Editor’s Note: HR+/HER2- is the most common subtype of breast cancer, accounting for approximately 65% to 70% of all breast cancer cases. Improving the survival benefits for patients with advanced…
-
AASLD Voice of China| Dr. Song Yang’s Team: Survival Prediction in Chinese Alcohol- Related Liver Disease — Sarcopenia is an Independent Factor, MELD
Editor’s Note: From November 10th to 14th, the annual highlight event in the field of hepatology, the American Association for the Study of Liver Diseases (AASLD) 2023 Annual Meeting, took…
-
AASLD 2023 Highlights: Conference Overview and Special Topics Collection
Editor’s Note: From November 10th to 14th, the annual grand event in the field of hepatology, the American Association for the Study of Liver Diseases (AASLD) Annual Meeting 2023, is…
-
AASLD Hot Updates on MASLD from the 2023 Annual Meeting
Editor’s Note: On November 7, 2023, at 12:30 PM local time in Boston, the American Association for the Study of Liver Diseases (AASLD) held its sole pre-conference press briefing on…
-
AASLD Exclusive Interview | Dr.Mark Yarchoan: Progress in the Treatment of Intermediate and Advanced HCC, Highlighting the Value of Systemic Therapy
Editor’s Note: At the recently concluded international annual flagship event in the field of hepatology – the American Association for the Study of Liver Diseases Annual Meeting (AASLD 2023), Professor…
-
Dr. Ting Niu: Population-based study reveals prognostic factors and clinical characteristics of gray zone lymphoma patients
From June 8th to 11th, 2023, the 28th European Hematology Association (EHA) annual conference was held grandly in Frankfurt, Germany. The EHA conferences have always been spectacular, with research on lymphoma consistently attracting significant attention. A study on gray zone lymphoma by Dr Ting Niu’s team from West China Hospital of Sichuan University ( Abstract…
Connecting Medical Expertise through Media